GlaxoSmithKline PLC (GSK)
43.55
-0.19 -0.43%
NYSE
Feb 18, 16:59
Delayed 2m
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 43.04B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 2.362 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 5.906B |
| Profitability | |
| Gross Profit Margin (Quarterly) | 63.50% |
| Profit Margin (Quarterly) | 14.60% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 4.67% |
| Price and Valuation | |
| Market Cap | 109.23B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 2.529 |
| PE Ratio | 18.43 |
| Price to Book Value | 6.952 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 2.546 |
| Free Cash Flow (Quarterly) | 3.574B |
| Return on Equity | Upgrade |
View All GSK News
News
-
WireHeadlineTime (ET)
-
Yahoo02/18 10:13
-
Yahoo02/18 08:00
-
Yahoo02/18 07:37
-
MT Newswires02/18 07:12
-
Yahoo02/18 05:00
-
PR Newswire02/17 10:00
-
Yahoo02/17 10:00
-
SA Breaking News02/14 17:04
-
Yahoo02/13 12:27
-
MT Newswires02/13 10:26
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 05/01/2020 | Earnings | GlaxoSmithKline PLC First Quarter Earnings Results in 2020 |
| 02/20/2020 | Dividends | Amount: 0.5994, Declared Date: Feb 05 2020, Pay Date: Apr 09 2020 |
| 02/05/2020 | Earnings | GlaxoSmithKline PLC Fourth Quarter Earnings Results in 2019 |
| 11/14/2019 | Dividends | Amount: 0.4998, Declared Date: Oct 30 2019, Pay Date: Jan 09 2020 |
| 10/30/2019 | Earnings | GlaxoSmithKline PLC Third Quarter Earnings Results in 2019 |
| 08/08/2019 | Dividends | Amount: 0.4658, Declared Date: Aug 07 2019, Pay Date: Oct 10 2019 |
| 07/24/2019 | Earnings | GlaxoSmithKline PLC Second Quarter Earnings Results in 2019 |
| 05/16/2019 | Dividends | Amount: 0.4730, Declared Date: May 02 2019, Pay Date: Jul 11 2019 |
| 05/08/2019 | Misc | GlaxoSmithKline PLC Annual General Meeting in 2018 |
| 05/01/2019 | Earnings | GlaxoSmithKline PLC First Quarter Earnings Results in 2019 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: http://www.gsk.com
- Investor Relations URL: http://www.gsk.com/en-gb/investors/
- HQ State/Province: N/A
- Sector: Healthcare
- Industry: Drug Manufacturers - General
- Equity Style: Large Cap/Blend
- Next Earnings Release: May. 01, 2020
- Last Earnings Release: Feb. 05, 2020
- Next Ex-Dividend Date: Feb. 20, 2020
- Last Ex-Dividend Date: Nov. 14, 2019
- Description: In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory and antiviral, as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 43.55 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| CIG11506 | CI Black Creek Global Leaders Class I | 5.90% |
| HHL.TO | Harvest Healthcare Leaders Income ETF | 5.03% |
| PPH | VanEck Vectors Pharmaceutical ETF | 4.49% |
| ACIO | Aptus Collared Income Opportunity ETF | 3.88% |
| JTA | Nuveen Tax-Adv Total Return | 2.36% |
| DODGX | Dodge & Cox Stock | 1.95% |
| GCOW | Pacer Global Cash Cows Dividend ETF | 1.91% |
| RRIGX | T. Rowe Price International Value Eq R | 1.90% |
| FGLGX | Fidelity® Series Large Cap Stock | 1.74% |
| DODBX | Dodge & Cox Balanced | 1.27% |
| EVT | EV Tax Advantaged Dividend Inc | 1.14% |
| PAEIX | T. Rowe Price Overseas Stock Advisor | 1.02% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- GSK Tweets Stocktwits
Advertisement
